MA28606B1 - Dérivés d'indazole et d'indolone et leur utilisation comme agents pharmaceutiques - Google Patents

Dérivés d'indazole et d'indolone et leur utilisation comme agents pharmaceutiques

Info

Publication number: MA28606B1
Authority: MA; Morocco
Prior art keywords: indolone; indazole; derivatives; pharmaceutical agents; pharmaceutical
Prior art date: 2004-05-26

Application number

MA29487A

Other languages

English (en)

Inventor

Charlotte Moira Norfor Allerton

David Hepworth

Duncan Charles Miller

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-26

Filing date

2006-11-24

Publication date

2007-05-02

2004-05-26 Priority claimed from GB0411810A external-priority patent/GB0411810D0/en

2004-07-09 Priority claimed from GB0415455A external-priority patent/GB0415455D0/en

2006-11-24 Application filed by Pfizer filed Critical Pfizer

2007-05-02 Publication of MA28606B1 publication Critical patent/MA28606B1/fr

Links

125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 title 1
QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical compound C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 title 1
FGFUBBNNYLNVLJ-UHFFFAOYSA-N indolone Natural products C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 title 1
239000008177 pharmaceutical agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA29487A 2004-05-26 2006-11-24 Dérivés d'indazole et d'indolone et leur utilisation comme agents pharmaceutiques MA28606B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0411810A GB0411810D0 (en)	2004-05-26	2004-05-26	New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en)	2004-07-09	2004-07-09	New indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number	Publication Date
MA28606B1 true MA28606B1 (fr)	2007-05-02

Family

ID=35219654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29487A MA28606B1 (fr)	2004-05-26	2006-11-24	Dérivés d'indazole et d'indolone et leur utilisation comme agents pharmaceutiques

Country Status (25)

Country	Link
EP (1)	EP1753763B1 (fr)
JP (2)	JP4093588B2 (fr)
AP (1)	AP2006003823A0 (fr)
AR (1)	AR049191A1 (fr)
AT (1)	ATE404560T1 (fr)
AU (1)	AU2005247696A1 (fr)
BR (1)	BRPI0511533A (fr)
CA (1)	CA2568050A1 (fr)
CR (1)	CR8772A (fr)
DE (1)	DE602005008954D1 (fr)
EA (1)	EA200601985A1 (fr)
EC (1)	ECSP067024A (fr)
ES (1)	ES2308492T3 (fr)
GT (1)	GT200500118A (fr)
IL (1)	IL179365A0 (fr)
MA (1)	MA28606B1 (fr)
MX (1)	MXPA06013759A (fr)
NL (1)	NL1029128C2 (fr)
NO (1)	NO20065328L (fr)
PA (1)	PA8635001A1 (fr)
PE (1)	PE20060289A1 (fr)
SV (1)	SV2005002128A (fr)
TW (1)	TW200607500A (fr)
UY (1)	UY28918A1 (fr)
WO (1)	WO2005116027A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR078411A1 (es)	2009-05-07	2011-11-09	Lilly Co Eli	Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
WO2012100347A1 (fr) *	2011-01-24	2012-08-02	Inceptum Research & Therapeutics, Inc.	Compositions comprenant une prostaglandine pour le traitement de pathologies neuropsychiatriques
WO2016071293A2 (fr) *	2014-11-03	2016-05-12	Iomet Pharma Ltd	Composé pharmaceutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0641202A1 (fr) *	1992-05-18	1995-03-08	Smithkline Beecham Plc	Emploi de derives d'indolone dans le traitement de troubles de la memoire, du dysfonctionnement sexuel et de la maladie de parkinson
AU6246198A (en) *	1997-02-18	1998-09-08	American Home Products Corporation	4-aminoethoxyindazole derivatives
GB0130219D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Compounds for the treatment of sexual dysfunction
OA13014A (en) *	2002-12-10	2006-11-10	Pfizer	Morpholine derivatives for use as dopamine agonists in the treatment of i.a sexual dysfunction.

2005
- 2005-05-17 JP JP2007514182A patent/JP4093588B2/ja not_active Expired - Fee Related
- 2005-05-17 ES ES05742759T patent/ES2308492T3/es not_active Expired - Lifetime
- 2005-05-17 BR BRPI0511533-7A patent/BRPI0511533A/pt not_active IP Right Cessation
- 2005-05-17 AT AT05742759T patent/ATE404560T1/de not_active IP Right Cessation
- 2005-05-17 DE DE602005008954T patent/DE602005008954D1/de not_active Expired - Fee Related
- 2005-05-17 WO PCT/IB2005/001513 patent/WO2005116027A2/fr not_active Ceased
- 2005-05-17 CA CA002568050A patent/CA2568050A1/fr not_active Abandoned
- 2005-05-17 EP EP05742759A patent/EP1753763B1/fr not_active Expired - Lifetime
- 2005-05-17 EA EA200601985A patent/EA200601985A1/ru unknown
- 2005-05-17 AU AU2005247696A patent/AU2005247696A1/en not_active Abandoned
- 2005-05-17 AP AP2006003823A patent/AP2006003823A0/xx unknown
- 2005-05-17 MX MXPA06013759A patent/MXPA06013759A/es unknown
- 2005-05-20 GT GT200500118A patent/GT200500118A/es unknown
- 2005-05-23 PE PE2005000570A patent/PE20060289A1/es not_active Application Discontinuation
- 2005-05-24 UY UY28918A patent/UY28918A1/es not_active Application Discontinuation
- 2005-05-24 AR ARP050102145A patent/AR049191A1/es unknown
- 2005-05-25 NL NL1029128A patent/NL1029128C2/nl not_active IP Right Cessation
- 2005-05-25 TW TW094117076A patent/TW200607500A/zh unknown
- 2005-05-26 PA PA20058635001A patent/PA8635001A1/es unknown
- 2005-05-26 SV SV2005002128A patent/SV2005002128A/es not_active Application Discontinuation
2006
- 2006-11-16 IL IL179365A patent/IL179365A0/en unknown
- 2006-11-20 NO NO20065328A patent/NO20065328L/no unknown
- 2006-11-24 MA MA29487A patent/MA28606B1/fr unknown
- 2006-11-24 EC EC2006007024A patent/ECSP067024A/es unknown
- 2006-11-24 CR CR8772A patent/CR8772A/es unknown
2007
- 2007-12-11 JP JP2007320093A patent/JP2008074874A/ja active Pending

Also Published As

Publication number	Publication date
NL1029128C2 (nl)	2006-06-14
CR8772A (es)	2006-12-13
ECSP067024A (es)	2006-12-29
DE602005008954D1 (de)	2008-09-25
NO20065328L (no)	2006-12-18
JP4093588B2 (ja)	2008-06-04
AP2006003823A0 (en)	2006-12-31
UY28918A1 (es)	2005-12-30
NL1029128A1 (nl)	2005-11-30
PA8635001A1 (es)	2006-05-16
GT200500118A (es)	2006-01-10
MXPA06013759A (es)	2007-02-08
TW200607500A (en)	2006-03-01
JP2008500329A (ja)	2008-01-10
CA2568050A1 (fr)	2005-12-08
JP2008074874A (ja)	2008-04-03
WO2005116027A3 (fr)	2006-04-13
PE20060289A1 (es)	2006-04-22
EP1753763B1 (fr)	2008-08-13
EP1753763A2 (fr)	2007-02-21
AR049191A1 (es)	2006-07-05
AU2005247696A1 (en)	2005-12-08
ES2308492T3 (es)	2008-12-01
WO2005116027A2 (fr)	2005-12-08
EA200601985A1 (ru)	2007-04-27
IL179365A0 (en)	2007-03-08
ATE404560T1 (de)	2008-08-15
BRPI0511533A (pt)	2008-01-02
SV2005002128A (es)	2005-12-13

Publication	Publication Date	Title
EP1765379A4 (fr)	2009-05-27	Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
FR24C1004I1 (fr)	2024-04-19	Formes galéniques de ganaxolone et procédés de preparation et d'utilisation de celles-ci
EP1933881A4 (fr)	2013-01-02	Compositions polymères solides pour administration et méthodes d'utilisation de celles-ci
EP1858926A4 (fr)	2011-05-11	Glycosaminoglycanases solubles et procédés de préparation et d'utilisation de glycosaminoglycanases solubles
EP2131848A4 (fr)	2012-06-27	Compositions et methodes de potentialisation de l'activite de molecules biologiquement actives
EP1740197A4 (fr)	2009-09-16	Preparation therapeutique a base d'enzymes et ses utilisations
MA28802B1 (fr)	2007-08-01	Utilisations therapeutiques d'inhibiteurs de rtp801
EP2024272A4 (fr)	2010-11-17	Dérivés d'amides en tant que ligands de canal ionique et compositions pharmaceutiques et méthodes d'utilisation desdits dérivés
DE602005002562D1 (de)	2007-10-31	Pyrrolylsubstituierte pyridoä2,3-düpyrimidin-7-one und derivate davon als therapeutische mittel
EE05585B1 (et)	2012-10-15	Indasoolihendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ning nende kasutamine
MA30655B1 (fr)	2009-08-03	Composes organiques.
EP2120566A4 (fr)	2010-07-14	Composés et compositions pharmaceutiques destinés au traitement d'infections virales
EP1773768A4 (fr)	2008-08-06	Derives de pyrrole en tant qu'agents pharmaceutiques
MA28489B1 (fr)	2007-03-01	Preparations pharmaceutiques
EP1727530A4 (fr)	2009-10-21	Formulations topiques pour le traitement d'etats dermatologiques
EP1718312A4 (fr)	2009-09-30	Compositions pharmaceutiques anti-inflammatoires synergiques et procedes associes utilisant des curcuminoides ou des methylxanthines
EP1965823A4 (fr)	2010-08-04	Procedes d'administration d'agents hypoglycemiques
EP1752150A4 (fr)	2012-06-20	Préparation d'irinotécan
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
MA26882A1 (fr)	2004-12-20	COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
EP1863859A4 (fr)	2009-04-22	Copolymeres greffes de peg-polyacetal et de peg-polyacetal-poe et compositions pharmaceutiques
MA28279A1 (fr)	2006-11-01	Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2
EP2164518A4 (fr)	2012-09-05	Formulations pour l'administration par voie orale d'agents thérapeutiques, et procédés associés
DE60327254D1 (de)	2009-05-28	Den getreideertrag erhöhendes gen und dessen nutzung
DE602004007268D1 (de)	2007-08-09	CYCLOALKYLSULFANYL-SUBSTITUIERTE BENZOiBöTHIOPHENE ALS THERAPEUTISCHE MITTEL